Becton, Dickinson And Co. (BDX)


Stay up to date

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Financial Statements

Key Info

  • Industry: Surgical and Medical Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Thomas Polen

Key Statistics

  • Stock Price: $252.22
  • Dividend Yield: 1.4000000000000001%
  • Market Capitalization: $71,103,948,337
  • Shares Outstanding: 284,267,974
  • Number of Employees: 77,000
  • Trailing 12-Month EPS: $5.88
  • Trailing 12-Month DPS: $3.48
  • Payout Ratio: 59.199999999999996%

Important Dates

  • Next Earnings Date: 2023-02-02
  • Next Ex-Dividend Date: 2022-12-08

Price Trends

  • Current Stock Price: $252.22
  • 52-week high: $274.41
  • 52-week low: $215.1
  • 200-day moving average: $243.11
  • 50-day moving average: $253.15


  • 1-Month Price Return: -1.6%
  • 3-Month Price Return: 6.7%
  • 6-Month Price Return: 3.1%
  • 1-Year Price Return: 1.6%
  • 2-Year Price Return: 0.6%
  • 5-Year Price Return: 12.0%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast